價(jià)格 | 詢價(jià) |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-25 |
中文名稱:Recombinant Human VEGF121 | 英文名稱:Recombinant Human VEGF121 |
有效期: 一年 | 產(chǎn)品類別: 重組蛋白 細(xì)胞因子 |
產(chǎn)品編號(hào) | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價(jià)格 |
P5590-1mg | Recombinant Human VEGF121 | 1mg | 20076.00元 |
Species | Gene ID | Accession | Source | Length | MW | Tag |
Human | 7422 | P15692 | Yeast | 121aa | 14.4~20kDa | - |
About this Antibody | |
Name | Recombinant Human VEGF121 (Recombinant Human Vascular Endothelial Growth Factor 121; rHuVEGF121);重組人血管內(nèi)皮生長(zhǎng)因子121 |
Synonyms | VPF; VEGF; MVCD1 |
Purity | >95% by SDS-PAGE and HPLC analyses. |
Biological Activity | Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells (HUVEC) is between 0.2-0.4ng/ml. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH 7.4. |
Endotoxin | Less than 0.1EU/μg of rHuVEGF121 as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions. |
Category | Cytokine |
Background | Vascular Endothelial Growth Factor is a sub-family of growth factors produced by cells, which stimulates vasculogenesis and angiogenesis. VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels. Humans express alternately spliced isoforms of 121, 145, 165, 183, 189, and 206 amino acids (a.a.) in length. VEGF production can be induced in cells that are not receiving enough oxygen. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. Recombinant human VEGF121 contains 121 amino acids residues and it is a disulfide-linked homodimer. In addition, it shares 88% a.a. with corresponding regions of mouse and rat, 96% with porcine, 95% with canine, and 93% with feline, equine and bovine VEGF, respectively. |
Amino Acid Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENCDKPR R |
包裝清單:
產(chǎn)品編號(hào) | 產(chǎn)品名稱 | 包裝 |
P5590-2μg | Recombinant Human VEGF121 | 2μg |
P5590-10μg | Recombinant Human VEGF121 | 10μg |
P5590-100μg | Recombinant Human VEGF121 | 100μg |
P5590-1mg | Recombinant Human VEGF121 | 1mg |
- | 說明書 | 1份 |
保存條件:
???????-20℃或更低溫度保存,至少一年有效。由于蛋白的每次凍融均會(huì)引起部分失活,所以首次配制成相應(yīng)濃度的儲(chǔ)存液后(請(qǐng)根據(jù)產(chǎn)品簡(jiǎn)介中Reconstitution一欄的信息配制儲(chǔ)存液),須分裝后-20℃或更低溫度凍存,以避免反復(fù)凍融。
注意事項(xiàng):
???????由于有些塑料管壁對(duì)某些蛋白有較強(qiáng)的吸附作用,溶液中的蛋白很容易粘附在管壁上,并且粘附后的蛋白很難與管壁分離。而載體蛋白(Carrier protein,如0.1% BSA等)的主要作用是預(yù)先封閉塑料管壁上的蛋白結(jié)合位點(diǎn),使細(xì)胞因子或重組蛋白不會(huì)粘附于管壁。所以一定要使用產(chǎn)品簡(jiǎn)介中Reconstitution一欄的信息配制儲(chǔ)存液。
???????本產(chǎn)品僅限于專業(yè)人員的科學(xué)研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內(nèi)。
???????為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。
成立日期 | 2007-07-19 (18年) | 注冊(cè)資本 | 1000.000000萬(wàn)人民幣 |
員工人數(shù) | 500人以上 | 年?duì)I業(yè)額 | ¥ 500萬(wàn)-1000萬(wàn) |
主營(yíng)行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學(xué),生物活性小分子 | 經(jīng)營(yíng)模式 | 試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2024-12-27 | |
¥1138 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2024-12-27 | |
詢價(jià) |
VIP8年
|
成都云希化工有限公司
|
2024-12-27 | |
¥1200 |
VIP3年
|
上海雅吉生物科技有限公司
|
2024-12-27 | |
詢價(jià) |
VIP2年
|
北京百普賽斯生物科技股份有限公司
|
2024-12-16 | |
¥2589.00 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
¥100 |
成都菁臨生物科技有限公司
|
2024-11-19 | ||
¥700 |
湖南宜科復(fù)合材料有限公司
|
2024-08-22 | ||
詢價(jià) |
Chengdu YoungShe Chemical Co.,Ltd
|
2021-05-08 | ||
詢價(jià) |
成都云希化工
|
2019-12-05 |